BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 14, 2025
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Breaking News: 100 days of uncertainty
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
Genentech to develop neurturin for neurodegenerative disorders
April 12, 1996
Genetic markers for manic depression discovered
April 12, 1996
Atypical antipsychotics from Spanish university
April 12, 1996
Generic fluoxetine available in Canada
April 5, 1996
Genentech files for new indication for alteplase
April 5, 1996
Zeneca selects NMDA antagonist for preclinical study
April 5, 1996
SIBIA , Ciba-Geigy collaborate to develop CNS drugs
April 5, 1996
GV-150526A in development for stroke
April 5, 1996
TR-810 delivers SOD to the nervous system
April 5, 1996
Novel ETA/ETB antagonist reduces brain injury
April 5, 1996
Previous
1
2
…
2736
2737
2738
2739
2740
2741
2742
2743
2744
Next
RSS